LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug joins fight against tough head and neck cancers
Disease control Recruiting nowThis early-stage study is testing whether adding a new oral drug called ipatasertib to the standard treatment of chemotherapy plus radiation is safe and more effective for people with locally advanced head and neck cancer. The main goal is to find the safest and most effective do…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Cancer surgeons test if less cutting leads to better recovery
Disease control Recruiting nowThis study is for people with advanced head and neck cancer who have already had drug treatment that shrunk their tumor. It aims to see if a less extensive surgery can work as well as the standard, more invasive surgery. Researchers will compare two groups: one gets the smaller s…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Qunxing Li,MD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New cancer injection trial offers hope for elderly patients ineligible for standard chemo
Disease control Recruiting nowThis study is testing whether adding a new nanoparticle injection (NBTXR3) to standard radiation therapy works better for controlling advanced head and neck cancer in elderly patients. It is for people aged 60 and older who cannot safely receive the usual platinum-based chemother…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Johnson & Johnson Enterprise Innovation Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope to stop Cancer's return after tough treatment
Disease control Recruiting nowThis large, global study is testing whether a new drug called volrustomig can help keep cancer from growing or spreading in people with advanced head and neck cancer who have just finished a standard course of chemotherapy and radiation. The trial will compare the drug to simply …
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Custom-Made vaccine aims to train immune system to fight advanced cancers
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to target the unique proteins on a patient's own cancer cells. It is being given alongside an existing immunotherapy drug (pembrolizumab) to see if the combination is safe and can help control advanced solid tumors that h…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Radiation boost powers immune attack on cancer before surgery
Disease control Recruiting nowThis study is testing a new two-part treatment given before surgery for advanced head and neck cancer. Doctors combine a low dose of radiation with an immunotherapy drug (an anti-PD-1 inhibitor) to try to shrink tumors and improve long-term results. The goal is to see if this com…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Xiwei XU • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC